Corrigendum to: RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathway

Author unknown

Open source

DOI
10.1093/neuonc/noag099
Published
2026-05-20
Container
Neuro-Oncology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noag099,
  title = {Corrigendum to: RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathway},
  year = {2026},
  journal = {Neuro-Oncology},
  doi = {10.1093/neuonc/noag099},
  url = {https://doi.org/10.1093/neuonc/noag099}
}

RIS

TY  - JOUR
TI  - Corrigendum to: RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathway
PY  - 2026
JO  - Neuro-Oncology
DO  - 10.1093/neuonc/noag099
UR  - https://doi.org/10.1093/neuonc/noag099
ER  - 

APA

Corrigendum to: RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathway. (2026). Neuro-Oncology. https://doi.org/10.1093/neuonc/noag099

Source records